Up to 93% of so-called Type I endometrial tumors (endometrioid type) are missing the phosphatase and tensin homologue (PTEN), or have mutations in the PI3K/Akt/mTOR pathways that it regulates [64, 65]. This evidence concerns the gene PTEN and endometrium neoplasm.